HHS Unveils $700M in Behavioral Health and Addiction Funding

HHS.GOV June 17, 2026
Read Full Article →
AI-Generated Summary

HHS will direct more than $700 million in new federal funding toward behavioral health and addiction treatment, Secretary Robert F. Kennedy Jr. announced June 17, 2026. The package includes $96 million for the new STREETS program, which will award eight communities up to $3 million annually for four years to coordinate street-based treatment for homeless individuals with substance use disorders or serious mental illness. Another $223.1 million goes to Certified Community Behavioral Health Clinics (CCBHCs) for service expansion, new-clinic development, and state Medicaid certification readiness, while $238.6 million strengthens 988 Suicide & Crisis Lifeline capacity, including $20 million for Tribal response. An additional $80 million targets substance use prevention and treatment, and over $70 million funds mental health services for at-risk children and families.

Why It Matters

Behavioral health and addiction treatment operators should track which CCBHC and STREETS grants land in their service areas — these awards fund new clinic development, certification readiness for Medicaid demonstration participation, and street-based care models that directly expand referral pipelines and payer-mix diversification.

behavioral health funding SAMHSA grants CCBHC addiction treatment 988 crisis lifeline federal grants healthcare mental health access

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

How much new federal funding did HHS announce for behavioral health in June 2026?

HHS announced more than $700 million in new funding opportunities on June 17, 2026, covering the STREETS program, Certified Community Behavioral Health Clinics, the 988 Suicide & Crisis Lifeline, and substance use prevention and treatment programs.

What is the STREETS program and how much funding does it provide?

STREETS (Safety Through Recovery, Engagement, and Evidence-based Treatment and Support) is a SAMHSA program that will award eight communities up to $3 million per year for four years, totaling $96 million, to build coordinated street-based treatment systems for homeless individuals with substance use disorders or serious mental illness.

How much funding is going to Certified Community Behavioral Health Clinics (CCBHCs)?

CCBHCs are receiving $223.1 million total: $117.1 million for Improvement and Advancement Grants, $94 million for Planning, Development, and Implementation Grants, and $12 million for State Planning Grants to prepare for the CCBHC Medicaid Demonstration Program.

Similar Posts

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.

  • Health System Leaders on Costs, Innovation, and the Affordability Challenge

    Top U.S. health system executives say affordability and cost pressure now sit at the center of nearly every strategic decision. In a Chief Healthcare Executive roundtable, leaders including Hackensack Meridian Health CEO Robert Garrett argued that systems must shift from treating illness toward preventing chronic disease and keeping communities healthy. Panelists framed innovation, particularly AI, as a double-edged force: either an ingredient in solving the affordability challenge or a threat to traditional business models. The group sees significant potential for new technology to transform operations and care delivery, while cautioning that disruption is inevitable and that executives must actively manage change rather than react to it.

  • Lilly and Novo Lead Pharma AI Citation Share: What the 5W Study Found

    Eli Lilly and Novo Nordisk are the most cited pharmaceutical companies across AI platforms, holding 12.5% and 11.5% of AI citation share respectively, according to a study by PR firm 5W covered by MM+M. Researchers ran common patient queries through ChatGPT, Claude, Gemini, Perplexity and Google AI Overviews, measuring which companies were named, cited and linked — and how extractable their source material was. Pfizer (8.5%), Johnson & Johnson (7%) and Merck (6%) round out the top five, with GLP-1 demand driving the leaders’ visibility. With roughly one-third of U.S. adults now using AI chatbots for health information, citation share is emerging as a measurable brand-visibility metric for healthcare marketers.

  • Federal Loan Caps Hit Dental Education: 8 Notes on Workforce Impact

    New federal student loan caps took effect July 1, limiting borrowing to $50,000 per year for professional degree programs — well below what the average dental student borrows at nearly every U.S. dental program, according to the ADA’s Health Policy Institute. Dental education shows the largest gap between average annual borrowing and the new cap of any healthcare training program, and more than 20,000 dental students received nearly $2 billion in federal loans under the prior rules. The caps, part of the 2025 One Big Beautiful Bill Act, also change loan repayment programs and GRAD PLUS loans. The ADA warns the limits could constrain the dental-school pipeline and shift practice trends as graduates respond to new debt pressures.

  • CMS Proposes Medicaid Payment Caps That Could Save $775B Over 10 Years

    CMS’s proposed rule would cap Medicaid Managed Care State Directed Payments at 100% of Medicare rates in expansion states and 110% in non-expansion states, projecting $775 billion in savings over 10 years, including $510 billion at the federal level. State Directed Payment use has grown from two states in 2016 to 41 states today, now accounting for more than a quarter of all Medicaid managed care spending, with unchecked growth projected to nearly triple SDP spending from $107 billion in FY2024 to $296 billion by FY2034. The rule, tied to the Working Families Tax Cut legislation and a 2025 presidential directive on Medicaid fraud, also tightens limits on certain fee-for-service practitioner payments and adds new transparency standards.